ESC 2022

ESC 2022 – Novo’s cardiovascular charge continues
EP Vantage
Thu, 09/1/22 - 10:13 am
ESC 2022
Novo Nordisk
ziltivekimab
PRX004
HS-001
ESC 2022 preview – who’s got the XI factor?
EP Vantage
Tue, 08/23/22 - 10:23 am
ESC 2022
Bristol Myers Squibb
JNJ
Bayer
Eliquis
Xarelto
bloodthinners
Lixiana
Pradaxa